Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Physiology
  • Track 1-2Diagnosis
  • Track 1-3Vascular systems
  • Track 1-4Circulatory diseases
  • Track 1-5Microcirculation
  • Track 1-6Specialization of vascular cells
  • Track 2-1Cardiovascular medicine
  • Track 2-2Peripheral artery disease
  • Track 2-3Coronary heart disease
  • Track 2-4Angioplasty and Stent
  • Track 2-5Renal artery stenosis
  • Track 2-6Thrombosis
  • Track 3-1Bypass surgery
  • Track 3-2Endoscopic perforator surgery
  • Track 3-3Aortobifemoral bypass
  • Track 3-4Thromboendarterectomy
  • Track 3-5Resection
  • Track 3-6Endovascular grafting
  • Track 3-7Heart Failure and Transplantation Medicine
  • Track 4-1Neovascularization
  • Track 4-2Vascular disrupting therapies
  • Track 4-3Tumor vasculature
  • Track 4-4Angiogenesis
  • Track 4-5Immunotherapy
  • Track 4-6Chemotherapy
  • Track 5-1Acute Management of Stroke
  • Track 5-2Basilar Artery Thrombosis
  • Track 5-3Cerebral Venous Thrombosis
  • Track 5-4Genetic and Inflammatory Mechanisms in Stroke
  • Track 5-5Hypertensive Encephalopathy
  • Track 5-6Lacunar Syndrome
  • Track 6-1Chronic venous insufficiency
  • Track 6-2Lymphatic diseases
  • Track 6-3Colorectal surgery
  • Track 6-4Thromboangitis
  • Track 6-5Vascular calcification
  • Track 6-6Thoracic aortic dissection
  • Track 7-1Vascular embolism
  • Track 7-2Abdominal aortic aneurysm
  • Track 7-3Pulmonary embolism
  • Track 7-4Abdominal aortic aneurysms
  • Track 7-5Aortic dissection
  • Track 7-6Acute limb ischemia
  • Track 7-7Arteriovenous fistulae (AVFs)
  • Track 8-1Aortic Stenosis
  • Track 8-2Neonatal lupus erythematosus
  • Track 8-3Childhood scleroderma
  • Track 8-4Arteriovenous malformations (AVM)
  • Track 8-5Coronary artery anomaly
  • Track 8-6Complete congenital heart block
  • Track 8-7Interventional cardiology
  • Track 9-1Scurvy
  • Track 9-2Marfan syndrome
  • Track 9-3Ehlers-Danlos Syndrome
  • Track 9-4Purpura simplex
  • Track 9-5Hereditary hemorrhagic telangiectasia
  • Track 9-6Dysproteinemias causing vascular purpura
  • Track 9-7Autoerythrocyte sensitization
  • Track 10-1Psychological therapy
  • Track 10-2Weight reduction
  • Track 10-3Non alcoholism and smoking
  • Track 10-4Exercise and yoga
  • Track 10-5Life style modifications
  • Track 10-6Food habits
  • Track 11-1Balloon angioplasty
  • Track 11-2Radiofrequency ablation (RF/RFA)
  • Track 11-3Electrophysiology study of the heart
  • Track 11-4Endovascular aneurysm repair
  • Track 11-5Embolization therapy
  • Track 11-6Thrombolysis
  • Track 12-1Ultrasound
  • Track 12-2Doppler ultrasound
  • Track 12-3Catheter angiography
  • Track 12-4Digital subtraction angiography
  • Track 12-5Intra vascular ultrasound
  • Track 12-6Magnetic resonance imaging
  • Track 12-7Power doppler
  • Track 13-1Stem cell therapy
  • Track 13-2Endothelial progenitor cell therapy
  • Track 13-3Trans-catheter aortic valve implantation
  • Track 13-4Minimally invasive bypass surgery
  • Track 13-5Trans-catheter aortic valve implantation
  • Track 13-6Gene therapy
  • Track 14-1Acute and chronic inflammation
  • Track 14-2Inflammatory diseases
  • Track 14-3Atherogenesis
  • Track 14-4Arterial hypertension
  • Track 14-5Anti-atherosclerotic therapies
  • Track 14-6Arteritis
  • Track 15-1Basic and Translational Research ipsc
  • Track 15-2Cell-free screening
  • Track 15-3Vascular targeting
  • Track 15-4Mitochondrial gene expression
  • Track 15-5Epigenetic, transcriptional and tumorigenic profiling
  • Track 15-6Genetic medicine
  • Track 16-1Vascular diabetology
  • Track 16-2Molecular studies
  • Track 16-3Tissue culture
  • Track 16-4Isolation
  • Track 16-5Metabolomics and genomics
  • Track 16-6Vascular biochemistry
  • Track 16-7Protein damage
  • Track 17-1Molecular biology
  • Track 17-2Basic and clinical translational methodologies
  • Track 17-3Hypothesis formulation
  • Track 17-4Cell therapy
  • Track 17-5Dose efficiency
  • Track 17-6Chronic remodeling
  • Track 17-7Experimental cardiology
  • Track 18-1Therapeutic drug monitoring in vascular pharmacotherapy
  • Track 18-2Individual patient drug regimen in vascular diseases
  • Track 18-3Basic pharmacotherapy in vascular diseases
  • Track 18-4Drug interactions in vascular pharmacotherapy
  • Track 18-5Advanced vascular pharmacotherapy
  • Track 18-6Adverse events in vascular pharmacotherapy